Article
Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients.
Journal of clinical pathology - 1 Jan 2015
Malapelle Umberto, Vigliar Elena, Sgariglia Roberta, Bellevicine Claudio, Colarossi Lorenzo, Vitale Domenico, Pallante Pierlorenzo, Troncone Giancarlo
Abstract excerpt
AIMS: To evaluate the accuracy, consumable cost and time around testing (TAT) of a next-generation sequencing (NGS) assay, the Ion Torrent AmpliSeq Colon and Lung Cancer Panel, as an alternative to Sanger sequencing to genotype KRAS, NRAS and BRAF in colorectal cancer patients. METHODS: The Ion Torrent panel was first verified on cell lines and on control samples and then prospectively applied to routine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
